Auto-Feedback Regulation of Beta-catenin in Human Cancer
人类癌症中β-连环蛋白的自动反馈调节
基本信息
- 批准号:7413306
- 负责人:
- 金额:$ 25.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-05-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AXIN2 proteinAdenomatous Polyposis ColiAllelesBiochemicalBiochemical GeneticsBiological ModelsBreedingCSNK1A1 geneCancer cell lineCell NucleusChimera organismChimeric ProteinsColorectal CancerDevelopmentDisruptionDoctor of PhilosophyDown-RegulationDoxycyclineEngineeringExonsF Box DomainFailureFeedbackFutureGene TargetingGenesGenetic EngineeringGoalsHomologous GeneHumanIndividualKnowledgeLaboratoriesLeadMalignant NeoplasmsMediatingMolecular ChaperonesMusMutant Strains MiceMutationNeoplastic Cell TransformationOncogenicPathogenesisPhosphorylationPrevention therapyReagentRegulationResearch PersonnelScaffolding ProteinScreening procedureSerineSignal TransductionTertiary Protein StructureTestingTherapeutic StudiesTissuesTumor Suppressor ProteinsUbiquitinbasebeta catenincDNA Librarycancer preventioncasein kinase Icellular targetingcolon cancer cell linedefined contributionhomologous recombinationin vitro Modelin vivointestinal epitheliumnovelpromoterresearch studyresponsetooltumortumorigenesisvector
项目摘要
DESCRIPTION (provided by applicant): Beta-catenin is a key activator of Wnt signaling target genes. Aberrant activation of beta-catenin through mutational inactivation of its negative regulators has been implicated in the pathogenesis of several common human cancers. Recent studies from our laboratory have demonstrated that beta-catenin is subject to an autofeedback regulation after the adenomatous polyposis coli (APC) tumor suppressor protein mediated regulatory mechanism failed due to mutation. Functional screening of a cDNA library constructed by enriching beta-catenin induced genes through subtraction has lead to the identification the scaffolding protein Axin2, a target gene of beta-catenin. A homolog of Conductin or mouse Axil, Axin2 was previously identified as a negative regulator of Wnt/beta-catenin signaling by several other laboratories. Our transient expression experiments revealed a novel function of Axin2 in the destruction of beta-catenin that is uniquely different from that of the APC-mediated regulatory mechanism. We hypothesize that auto-feedback regulation of beta-catenin by Axin2 is an important mechanism of canonical Wnt/beta-catenin signaling. Based on this hypothesis, we suggest: 1) downregulation of beta-catenin requires a synergetic effect contributed by both APC and Axin 2; and 2) failure of Axin2-mediated auto-feedback regulation will lead to aberrant activation of beta-catenin and consequently neoplastic transformation. We propose to test this hypothesis using a combination of genetic and biochemical approaches as outlined in the following specific aims. AIM I: To assess whether synergistic cooperation between APC and Axin2 is required for the downregulation of beta-catenin using a set of genetically engineered colon cancer cell lines as the in vitro model system; and AIM II: To test whether loss of the auto-feedback function of Axin2 will cause aberrant activation of beta-catenin and tumorigenesis in vivo using genetically engineered mutant mice harboring heterozygous Axin2 allele. AIM III: To define the contribution of individual protein domains to the Axin2 tumor suppressor function, and use these information to delineate the unique features in Axin2-mediated destruction of beta-catenin. The long term goal of these proposed studies is to gain new mechanistic information concerning the pathogenesis of beta-catenin in human cancer, with the objective of identifying key cellular targets useful for rational cancer prevention and therapy.
描述(由申请人提供):β -连环蛋白是Wnt信号靶基因的关键激活因子。β -连环蛋白通过其负调节因子的突变失活而异常激活,与几种常见人类癌症的发病机制有关。我们实验室最近的研究表明,在大肠腺瘤性息肉病(APC)肿瘤抑制蛋白介导的调节机制因突变而失效后,β -连环蛋白受到自反馈调节。对β -catenin诱导基因进行减法富集构建的cDNA文库进行功能筛选,鉴定出β -catenin的靶基因——支架蛋白Axin2。作为传导素或小鼠Axil的同源物,Axin2先前被其他几个实验室鉴定为Wnt/ β -连环蛋白信号的负调节因子。我们的瞬时表达实验揭示了Axin2在破坏β -连环蛋白中的一种新功能,这种功能与apc介导的调节机制截然不同。我们假设Axin2对β -catenin的自反馈调节是典型Wnt/ β -catenin信号传导的重要机制。基于这一假设,我们认为:1)β -catenin的下调需要APC和Axin 2的协同作用;2) axin2介导的自反馈调节的失败将导致β -连环蛋白的异常激活,从而导致肿瘤转化。我们建议使用遗传和生化方法的结合来检验这一假设,如下所述的具体目标。目的1:利用一组基因工程结肠癌细胞系作为体外模型系统,评估APC和Axin2是否需要协同合作下调β -连环蛋白;AIM II:利用携带杂合Axin2等位基因的基因工程突变小鼠,检测Axin2自反馈功能的丧失是否会导致体内β -连环蛋白的异常激活和肿瘤发生。目的III:定义单个蛋白结构域对Axin2肿瘤抑制功能的贡献,并利用这些信息描述Axin2介导的β -连环蛋白破坏的独特特征。这些拟议的研究的长期目标是获得关于β -连环蛋白在人类癌症发病机制的新机制信息,目的是确定有助于合理预防和治疗癌症的关键细胞靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BO LIU其他文献
BO LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BO LIU', 18)}}的其他基金
Auto-Feedback Regulation of Beta-catenin in Human Cancer
人类癌症中β-连环蛋白的自动反馈调节
- 批准号:
6908698 - 财政年份:2005
- 资助金额:
$ 25.03万 - 项目类别:
Auto-Feedback Regulation of Beta-catenin in Human Cancer
人类癌症中β-连环蛋白的自动反馈调节
- 批准号:
7233225 - 财政年份:2005
- 资助金额:
$ 25.03万 - 项目类别:
Auto-Feedback Regulation of Beta-catenin in Human Cancer
人类癌症中β-连环蛋白的自动反馈调节
- 批准号:
7059441 - 财政年份:2005
- 资助金额:
$ 25.03万 - 项目类别:
Auto-Feedback Regulation of Beta-catenin in Human Cancer
人类癌症中β-连环蛋白的自动反馈调节
- 批准号:
7608745 - 财政年份:2005
- 资助金额:
$ 25.03万 - 项目类别:
MOLECULAR BASIS OF HNPCC--HEREDITARY NONPOLYPOSIS COLORE
HNPCC的分子基础--遗传性非息肉病颜色
- 批准号:
6174070 - 财政年份:1999
- 资助金额:
$ 25.03万 - 项目类别:
MOLECULAR BASIS OF HNPCC--HEREDITARY NONPOLYPOSIS COLORE
HNPCC的分子基础--遗传性非息肉病颜色
- 批准号:
6377139 - 财政年份:1999
- 资助金额:
$ 25.03万 - 项目类别:
MOLECULAR BASIS OF HNPCC--HEREDITARY NONPOLYPOSIS COLORE
HNPCC的分子基础--遗传性非息肉病颜色
- 批准号:
2837816 - 财政年份:1999
- 资助金额:
$ 25.03万 - 项目类别:
MOLECULAR BASIS OF HNPCC--HEREDITARY NONPOLYPOSIS COLORE
HNPCC的分子基础--遗传性非息肉病颜色
- 批准号:
6633388 - 财政年份:1999
- 资助金额:
$ 25.03万 - 项目类别:
MOLECULAR BASIS OF HNPCC--HEREDITARY NONPOLYPOSIS COLORE
HNPCC的分子基础--遗传性非息肉病颜色
- 批准号:
6513549 - 财政年份:1999
- 资助金额:
$ 25.03万 - 项目类别:
相似海外基金
Roles for Adenomatous polyposis coli in colon injury prevention and wound healing
腺瘤性大肠杆菌在预防结肠损伤和伤口愈合中的作用
- 批准号:
10707443 - 财政年份:2022
- 资助金额:
$ 25.03万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10063347 - 财政年份:2020
- 资助金额:
$ 25.03万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10217057 - 财政年份:2020
- 资助金额:
$ 25.03万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10653134 - 财政年份:2020
- 资助金额:
$ 25.03万 - 项目类别:
Inhibition of the Wnt Receptor Complex by the Tumor Suppressor Adenomatous Polyposis Coli
抑癌基因腺瘤性息肉病大肠杆菌对 Wnt 受体复合物的抑制
- 批准号:
10424450 - 财政年份:2020
- 资助金额:
$ 25.03万 - 项目类别:
The molecular mechanism of adenomatous polyposis coli-binding protein EB1 in HCC
腺瘤性息肉病大肠杆菌结合蛋白EB1在肝癌中的分子机制
- 批准号:
25430134 - 财政年份:2013
- 资助金额:
$ 25.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expressioon of Adenomatous Polyposis Coli protein in the mouse cochlea.
腺瘤性息肉病大肠杆菌蛋白在小鼠耳蜗中的表达。
- 批准号:
24592538 - 财政年份:2012
- 资助金额:
$ 25.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tumor suppressor adenomatous polyposis coli and breast carcinogenesis
抑癌性腺瘤性结肠息肉病与乳腺癌发生
- 批准号:
7234812 - 财政年份:2003
- 资助金额:
$ 25.03万 - 项目类别:
Inactivation model of human Adenomatous Polyposis Coli gene by using budding yeast in vivo.
利用芽殖酵母体内的人腺瘤性息肉病大肠杆菌基因失活模型。
- 批准号:
10470129 - 财政年份:1998
- 资助金额:
$ 25.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Immunohistochemical and molecular biological study on abnormality of adenomatous polyposis coli gene in oral cancer and premalignant lesion.
口腔癌及癌前病变中腺瘤性息肉病基因异常的免疫组织化学和分子生物学研究。
- 批准号:
07671962 - 财政年份:1995
- 资助金额:
$ 25.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)